Novel Biomarkers for Predicting Preeclampsia
Author Information
Author(s): David M. Carty, Christian Delles, Anna F. Dominiczak
Primary Institution: BHF Glasgow Cardiovascular Research Centre, University of Glasgow
Hypothesis
Can novel biomarkers improve the prediction of preeclampsia?
Conclusion
The ability to predict preeclampsia has not significantly improved despite decades of research, but novel biomarkers show promise for early detection.
Supporting Evidence
- Preeclampsia complicates 3%-5% of pregnancies in the western world.
- Identifying at-risk women is crucial for timely intervention.
- Novel biomarkers like sFLT-1 and sEng show potential for early prediction.
Takeaway
Preeclampsia is a serious pregnancy condition that can be hard to predict, but researchers are looking for new signs that could help doctors catch it early.
Methodology
The review examines various biomarkers and their potential for predicting preeclampsia based on existing studies.
Potential Biases
Potential biases in study designs and definitions of preeclampsia may affect results.
Limitations
Many studies have small sample sizes and ambiguous definitions of preeclampsia.
Participant Demographics
The review references studies involving women with varying risk factors for preeclampsia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website